Company intelligence / Profile preview

Hilbert Paradox

Ownership: Private
Development stage: Other

Overview

Hilbert Paradox developed a digital health data management platform that enabled the capture and integration of isolated digital health data silos. The system used advanced analytics and artificial intelligence to process large volumes of healthcare-related data—including genomics, diagnostic devices, biosensors, and wearables—to accelerate research. The company was acquired by Genae in March 2018[1].

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Hilbert Paradox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hilbert Paradox.

Explore the full profile